MeiraGTx Holdings plc
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | |
|---|---|---|
| | | MeiraGTx Holdings plc (Registrant) |
| | | |
| Date: March 30, 2026 | By: | /s/ Alexandria Forbes |
| | | Alexandria Forbes |
| | | President and Chief Executive Officer and Director (Principal Executive Officer) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Registrant and in the capacities and on the dates indicated.
| Signature | Title | | | Date |
|---|---|---|---|---|
| | | | | |
| /s/ Alexandria Forbes, Ph.D. | President and Chief Executive Officer and Director(Principal Executive Officer) | | | March 30, 2026 |
| Alexandria Forbes, Ph.D. | | |||
| | | | | |
| /s/ Richard Giroux | Chief Financial Officer(Principal Financial and Accounting Officer) | | | March 30, 2026 |
| Richard Giroux | | |||
| | | | | |
| /s/ Keith R. Harris, Ph.D. | Chairman of the Board and Director | | | March 30, 2026 |
| Keith R. Harris, Ph.D. | ||||
| | | |||
| /s/ Ellen Hukkelhoven, Ph.D. | Director | | | March 30, 2026 |
| Ellen Hukkelhoven, Ph.D. | ||||
| | | |||
| /s/ Lord Mendoza | Director | | | March 30, 2026 |
| Lord Mendoza | ||||
| | | |||
| /s/ Nicole Seligman | Director | | | March 30, 2026 |
| Nicole Seligman | ||||
| | | |||
| /s/ Thomas E. Shenk, Ph.D. | Director | | | March 30, 2026 |
| Thomas E. Shenk, Ph.D. | ||||
| | | | | |
| /s/ Debra Yu, M.D. | Director | | | March 30, 2026 |
| Debra Yu, M.D. | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.